These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35754202)

  • 21. The role of the platelet function analyser (PFA-100) in the characterization of patients with von Willebrand's disease and its relationships with von Willebrand factor and the ABO blood group.
    Nitu-Whalley IC; Lee CA; Brown SA; Riddell A; Hermans C
    Haemophilia; 2003 May; 9(3):298-302. PubMed ID: 12694521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality control of platelets during storage by the PFA-100: a comparison to platelet aggregation.
    Beck KH
    Transfus Apher Sci; 2002 Dec; 27(3):247-53. PubMed ID: 12509220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of Platelet Function Analyzer-100 for Laboratory Detection of Anti-Platelet Drug-Induced Platelet Dysfunction.
    Kweon OJ; Lim YK; Kim B; Lee MK; Kim HR
    Ann Lab Med; 2019 Jan; 39(1):23-30. PubMed ID: 30215226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
    Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High resolution multimer analysis and the PFA-100 platelet function analyser can detect von Willebrand disease type 2A without a pathological ratio of ristocetin cofactor activity and von Willebrand antigen level.
    Weiss DR; Strasser EF; Ringwald J; Zimmermann R; Eckstein R
    Clin Lab; 2012; 58(11-12):1203-9. PubMed ID: 23289190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of bleeding history, von Willebrand factor and PFA-100(®) on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM-1VWD.
    Castaman G; Tosetto A; Goodeve A; Federici AB; Lethagen S; Budde U; Batlle J; Meyer D; Mazurier C; Goudemand J; Eikenboom J; Schneppenheim R; Ingerslev J; Habart D; Hill F; Peake I; Rodeghiero F
    Br J Haematol; 2010 Nov; 151(3):245-51. PubMed ID: 20738304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic performance of the platelet function analyzer (PFA-100) for the detection of disorders of primary haemostasis in patients with a bleeding history-a systematic review and meta-analysis.
    Karger R; Donner-Banzhoff N; Müller HH; Kretschmer V; Hunink M
    Platelets; 2007 Jun; 18(4):249-60. PubMed ID: 17538845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the PFA-100 system in the diagnosis and therapeutic monitoring of patients with von Willebrand disease.
    Cattaneo M; Federici AB; Lecchi A; Agati B; Lombardi R; Stabile F; Bucciarelli P
    Thromb Haemost; 1999 Jul; 82(1):35-9. PubMed ID: 10456451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility of the PFA-100 instrument and the novel multiplate analyzer for the assessment of aspirin and clopidogrel effects on platelet function in patients with cardiovascular disease.
    Mueller T; Dieplinger B; Poelz W; Haltmayer M
    Clin Appl Thromb Hemost; 2009 Dec; 15(6):652-9. PubMed ID: 18805846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2.
    van Vliet HH; Kappers-Klunne MC; Leebeek FW; Michiels JJ
    Thromb Haemost; 2008 Sep; 100(3):462-8. PubMed ID: 18766263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The platelet function analyzer (PFA-100) may not be suitable for monitoring the therapeutic efficiency of von willebrand concentrate in type III von willebrand disease.
    Meskal A; Vertessen F; Van der Planken M; Berneman ZN
    Ann Hematol; 1999 Sep; 78(9):426-30. PubMed ID: 10525831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of the Platelet Function Analyzer (PFA)-100 and platelet aggregometry in the differentiation of essential thrombocythemia from reactive thrombocytosis.
    Tsantes AE; Dimoula A; Bonovas S; Mantzios G; Tsirigotis P; Zoi K; Kalamara E; Kardoulaki A; Sitaras N; Travlou A; Dervenoulas J; Vaiopoulos G
    Thromb Res; 2010 Feb; 125(2):142-6. PubMed ID: 19664802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for von Willebrand disease with a new analyzer using high shear stress: a study of 60 cases.
    Fressinaud E; Veyradier A; Truchaud F; Martin I; Boyer-Neumann C; Trossaert M; Meyer D
    Blood; 1998 Feb; 91(4):1325-31. PubMed ID: 9454763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet dysfunction in primary thrombocythemia using the platelet function analyzer, PFA-100.
    Cesar JM; de Miguel D; García Avello A; Burgaleta C
    Am J Clin Pathol; 2005 May; 123(5):772-7. PubMed ID: 15981818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative evaluation of Plateletworks, Multiplate analyzer and Platelet function analyzer-200 in cardiology patients.
    Kim J; Cho CH; Jung BK; Nam J; Seo HS; Shin S; Lim CS
    Clin Hemorheol Microcirc; 2018; 70(3):257-265. PubMed ID: 29710682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct evidence for normalization of platelet function resulting from platelet count reduction in essential thrombocythemia.
    Tsantes AE; Nikolopoulos GK; Tsirigotis P; Zoi K; Zomas A; Kapsimali V; Kopterides P; Chondropoulos S; Dervenoulas J; Mantzios G
    Blood Coagul Fibrinolysis; 2011 Sep; 22(6):457-62. PubMed ID: 21836466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variability and persistence of aspirin response in lower extremity peripheral arterial disease patients.
    Saunders J; Nambi V; Kimball KT; Virani SS; Morrisett JD; Lumsden AB; Ballantyne CM; Dong JF;
    J Vasc Surg; 2011 Mar; 53(3):668-75. PubMed ID: 21227624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of regression analysis in determining reference intervals for low hematocrit and thrombocyte count in multiple electrode aggregometry and platelet function analyzer 100 testing of platelet function.
    Kuiper GJAJM; Houben R; Wetzels RJH; Verhezen PWM; Oerle RV; Ten Cate H; Henskens YMC; Lancé MD
    Platelets; 2017 Nov; 28(7):668-675. PubMed ID: 28067094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of primary hemostasis by PFA-100 analysis in a tertiary care center.
    Ortel TL; James AH; Thames EH; Moore KD; Greenberg CS
    Thromb Haemost; 2000 Jul; 84(1):93-7. PubMed ID: 10928477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variability in platelet responses to collagen--comparison between whole blood perfusions, traditional platelet function tests and PFA-100.
    Lepäntalo A; Beer JH; Siljander P; Syrjälä M; Lassila R
    Thromb Res; 2001 Jul; 103(2):123-33. PubMed ID: 11457470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.